» Articles » PMID: 34755080

Real-time Monitoring of Deformed Wing Virus-infected Bee Foraging Behavior Following Histone Deacetylase Inhibitor Treatment

Overview
Journal iScience
Publisher Cell Press
Date 2021 Nov 10
PMID 34755080
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Impairment in the learning/memory behavior of bees is responsible for the massive disappearance of bee populations and its consequent agricultural economic losses. Such impairment might be because of o both pesticide exposure and pathogen infection, with a key contributor deformed wing virus (DWV). The present study found that sodium butyrate (NaB) significantly increased survival and reversed the learning/memory impairment of DWV-infected bees. A next-generation sequencing analysis showed that NaB affected the expression of genes involved in glycolytic processes and memory formation, which were suppressed by DWV infection. In addition, we performed a large-scale movement tracking experiment by using a wireless sensor network-based automatic real-time monitoring system and confirmed that NaB could improve the homing ability of DWV-infected bees. In short, we demonstrated the mechanism of how epigenetic regulation can resume the memory function of honeybees and suggest strategies for applying NaB to reduce the incidence of colony losses.

Citing Articles

Learning performance and GABAergic pathway link to deformed wing virus in the mushroom bodies of naturally infected honey bees.

Szymanski S, Baracchi D, Dingle L, Bowman A, Manfredini F J Exp Biol. 2024; 227(13).

PMID: 38894668 PMC: 11418184. DOI: 10.1242/jeb.246766.

References
1.
Schroeder D, Martin S . Deformed wing virus: the main suspect in unexplained honeybee deaths worldwide. Virulence. 2012; 3(7):589-91. PMC: 3545936. DOI: 10.4161/viru.22219. View

2.
Fuchikami M, Yamamoto S, Morinobu S, Okada S, Yamawaki Y, Yamawaki S . The potential use of histone deacetylase inhibitors in the treatment of depression. Prog Neuropsychopharmacol Biol Psychiatry. 2015; 64:320-4. DOI: 10.1016/j.pnpbp.2015.03.010. View

3.
Shein N, Shohami E . Histone deacetylase inhibitors as therapeutic agents for acute central nervous system injuries. Mol Med. 2011; 17(5-6):448-56. PMC: 3105144. DOI: 10.2119/molmed.2011.00038. View

4.
McKinsey T . Targeting inflammation in heart failure with histone deacetylase inhibitors. Mol Med. 2011; 17(5-6):434-41. PMC: 3105143. DOI: 10.2119/molmed.2011.00022. View

5.
Vecsey C, Hawk J, Lattal K, Stein J, Fabian S, Attner M . Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBP-dependent transcriptional activation. J Neurosci. 2007; 27(23):6128-40. PMC: 2925045. DOI: 10.1523/JNEUROSCI.0296-07.2007. View